Finch Therapeutics Group Inc
Change company Symbol lookup
Select an option...
FNCH Finch Therapeutics Group Inc
TOL Toll Brothers Inc
TGEN Tecogen Inc
EPAM Epam Systems Inc
ISLE Isleworth Healthcare Acquisition Corp
TRMD Torm PLC
THC Tenet Healthcare Corp
BKCC BlackRock Capital Investment Corp
VIR Vir Biotechnology Inc
CBH Virtus Convertible & Income 2024 Target Term Fund
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Finch Therapeutics Group, Inc. is a clinical-stage microbiome therapeutics company. It is engaged in leveraging its Human-First Discovery platform to develop a class of orally administered biological drugs. Its Human-First Discovery platform uses reverse translation to identify diseases of dysbiosis and to design microbiome therapeutics that address them. Its lead product candidate, CP101, is an orally administered complete microbiome therapeutic in development for the prevention of recurrent Clostridioides difficile infection (CDI). CP101, consists of a microbial community harvested from rigorously screened healthy donors that is lyophilized and formulated in orally administered capsules designed to release at the appropriate location in the gastrointestinal tract. CP101 is designed to deliver a complete microbiome, addressing the community-level dysbiosis that characterizes CDI. Its product pipeline includes FIN-211, TAK-524, and FIN-525, as well as consortia product candidates.

Price
Delayed
$2.83
Day's Change
-0.05 (-1.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.85
Day's Low
2.80
Volume
(Light)

Today's volume of 11,051 shares is on pace to be much lighter than FNCH's 10-day average volume of 197,256 shares.

11,051
  • Prev Close
    2.88
  • Today's Open
    2.84
  • Day's Range
    2.80-2.85
  • Avg Vol (10-day)
    197.3K
  • Last (time)
    11:34a ET 07/06/22
  • Last (size)
    100
  • 52-Wk Range
    1.71 - 17.39
    LowHigh
  • (12/01/21 - 05/11/22)
    65.33%
  • 89.3%
  • Market Cap
    134.6M
  • Shares Outstanding
    47.6M
  • -1.45
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 22.25
  • (% of float 06/15/22)
    2.80

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.